Germany· DE-A57-b0cbc0b6d02c2514
Cefotaxim Eberth
A cefotaxime product containing cefotaxime sodium, registered in Germany by Dr. Friedrich Eberth Arzneimittel Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Cefotaxime is registered in 18 of 19 countries.
Countries holding a registration under ATC J01DD01 (cefotaxime), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 10 of them publish a price we can compare per daily dose
Cefotaxime · ATC J01DD01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefotaxime costs, country by country.
Normalised to the WHO defined daily dose (4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefotaxime · price per daily dose (4 g)
USD · FX 28 Sept 2026
- ES Spain$14.21
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Cefotaxime Sodium
- Manufacturer
- Dr. Friedrich Eberth Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- J01DD01
- ATC class
- Cefotaxime
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
104 interactions on record for cefotaxime.
Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefotaxime · interactions on record
104 records
- 21 moderate
- 83 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefotaxime in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCefotaxime 1g powder for solution for injection vialsLupin Healthcare (UK) Ltd
- FinlandCefotaxim AbbottAbbott Scandinavia AB
- CzechiaCEFOTAXIME HAMELNhameln pharma gmbh, Hameln
- SpainCEFOTAXIMA IPS 2 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE IV EFGI P S Farma S.L.
- ItalyBATIXIMSO.SE.PHARM S.R.L.
- BelgiumCefotaxim Sandoz 1 gSandoz
- IrelandCefotaxime 1 g powder for solution for injection/infusionNoridem Enterprises Limited
- SwedenCefotaxim hameln 1 g Pulver till injektions-/infusionsvätska, lösningHameln Pharma gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Cefotaxim Aptapharma, Cefotaxim Eberth
- Belgium · Cefotaxime Noridem, Claforan
- Bulgaria · Валоран, Тенатаксим
- Cyprus · Oximezin, Syntoxime
- Czechia · Cefotaxim Hameln, Cefotaxime Swyssi
- Denmark · Cefotaxim "hameln", Cefotaxim Mip
- Estonia · Cefotaxime Mip, Valoran
- Spain · Cefotaxima Normon, Cefotaxima Sala
- Finland · Cefotaxim Hameln, Cefotaxim Mip Pharma
- France · Cefotaxime Noridem, Cefotaxime Panpharma
- United Kingdom (Northern Ireland) · Cefotaxime Cox Pharmaceutical, Cefotaxime Hameln Pharma
- Greece · Ciltiren, Gloryfen
- Croatia · Cefotaksim Aptapharma, Cefotaksim Mip
- Hungary · Cefotaxim Aptapharma, Cefotaxime Swyssi
- Ireland · Cefotaxime Hameln, Cefotaxime Noridem Enterprises
- Iceland · Cefotaxim Navamedic
- Italy · Batixim, Cefotaxim Hameln
- Lithuania · Cefotaxime Mip
- Luxembourg · Cefotaxime Noridem, Claforan
- Latvia · Cefotaxime Mip
- Malta · Valoran
- Netherlands · Cefotaxim Hameln
- Norway · Cefotaxim Hameln, Cefotaxim Mip
- Poland · Biotaksym, Cefotaxim Mip
- Portugal · Antadar, Antadar I.M.
- Romania · Cefotax, Cefotaxim Mip
- Sweden · Cefotaxim Hameln, Cefotaxim Mip
- Slovenia · Cefotaksim Aptapharma, Valoran
- Slovakia · Cefotaxim Eberth, Cefotaxime Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9ccf57a1-1171-4a69-86f4-d630b0eb9118 GET /v1/drugs/9ccf57a1-1171-4a69-86f4-d630b0eb9118?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Cefotaxime Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about cefotaxime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.